<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:hpo ids='HP_0011420'>death</z:hpo> receptor CD95 promotes <z:mpath ids='MPATH_3'>apoptosis</z:mpath> through well-defined signalling pathways </plain></SENT>
<SENT sid="1" pm="."><plain>In <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells, CD95 primarily stimulates migration and invasion through pathways that are incompletely understood </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we identify a new CD95-activated tyrosine kinase pathway that is essential for CD95-stimulated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cell invasion </plain></SENT>
<SENT sid="3" pm="."><plain>We show that CD95 promotes Tyr 783 phosphorylation of phospholipase C-γ1 through the platelet-derived growth factor receptor-β, resulting in ligand-stimulated phosphatidylinositol (4,5)-bisphosphate (PIP(2)) hydrolysis </plain></SENT>
<SENT sid="4" pm="."><plain>PIP(2) hydrolysis liberates the actin-severing protein cofilin from the plasma membrane to initiate cortical actin remodelling </plain></SENT>
<SENT sid="5" pm="."><plain>Cofilin activation is required for CD95-stimulated formation of membrane protrusions and increased <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cell invasion </plain></SENT>
</text></document>